BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37588946)

  • 1. Varying Phenotypes of Leydig Cell Hyperplasia of the Ovary: Two Case Reports.
    Caulkins M; Ricciuti J; Desouki M; Mager KL
    Case Rep Obstet Gynecol; 2023; 2023():7178201. PubMed ID: 37588946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
    Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
    Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leydig tumor in normal sized ovaries causing clitoromegaly: A case report.
    Chavez TF; Singh M; Avadhani V; Leonis R
    Gynecol Oncol Rep; 2024 Apr; 52():101345. PubMed ID: 38435349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
    Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
    Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
    Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
    J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Report: Ovarian Sertoli-Leydig Cell Tumor With Hyperestrogenism and Endometrial Hyperplasia in a Postmenopausal Woman.
    Tsuzuki Y; Kikuchi I; Nojima M; Yoshida K; Hashizume A; Tomita S
    Jpn Clin Med; 2017; 8():1179066017695239. PubMed ID: 28469526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.
    Suturina LV; Sharifulin EM; Sharifulin MA; Lazareva LM; Danusevich IN; Ievleva KD; Nadeliaeva IG
    Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
    Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
    J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
    Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
    Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leydig cell hyperplasia in children: Case series and review.
    Mennie N; King SK; Marulaiah M; Ferguson P; Heloury Y; Kimber C
    J Pediatr Urol; 2017 Apr; 13(2):158-163. PubMed ID: 28238607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virilizing leydig-sertoli cell ovarian tumor associated with endometrioid carcinoma of the endometrium in a postmenopausal patient: case report and general considerations.
    Di Giacinto P; Chioma L; Vancieri G; Guccione L; Cicerone E; Ulisse S; Mariani S; Autore C; Fabbri A; Gnessi L; Moretti C
    Clin Med Insights Case Rep; 2012; 5():149-53. PubMed ID: 23133317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman.
    Mehta JM; Miller JL; Cannon AJ; Mardekian SK; Kenyon LC; Jabbour SA
    Case Rep Endocrinol; 2014; 2014():762745. PubMed ID: 25045549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
    Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
    Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
    Johnson JE; Hussain M; Rathore A; Wolfe K
    Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Bilateral Salpingo-Oophorectomy at Hysterectomy: Differences by Race and Menopausal Status in the Veterans Affairs Health Care System, 2007-2014.
    Bossick AS; Katon JG; Gray KE; Ma EW; Callegari LS
    J Womens Health (Larchmt); 2020 Dec; 29(12):1513-1519. PubMed ID: 33095114
    [No Abstract]   [Full Text] [Related]  

  • 20. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
    Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
    Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.